International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 2: T2 substaging and prostate cancer volume.
about
Targeted androgen pathway suppression in localized prostate cancer: a pilot study.Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance.Identification of pathologically insignificant prostate cancer is not accurate in unscreened men.Preoperative erectile function and the pathologic features of prostate cancer.The relationship of TMPRSS2-ERG gene fusion between primary and metastatic prostate cancers.F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients.Dataset for reporting of prostate carcinoma in radical prostatectomy specimens: recommendations from the International Collaboration on Cancer Reporting.Defining the threshold for significant versus insignificant prostate cancer.Supporting prostate cancer focal therapy: a multidisciplinary International Consensus of Experts ("ICE").1.5-T multiparametric MRI using PI-RADS: a region by region analysis to localize the index-tumor of prostate cancer in patients undergoing prostatectomy.Variation between specialist uropatholgists in reporting extraprostatic extension after radical prostatectomy.Ex vivo MRI evaluation of prostate cancer: Localization and margin status prediction of prostate cancer in fresh radical prostatectomy specimens.Predicting Gleason score using the initial serum total prostate-specific antigen in Black men with symptomatic prostate adenocarcinoma in Nigeria.Multiparametric magnetic resonance imaging and active surveillance: How to better select insignificant prostate cancer?The association between tumour density and prostate cancer recurrence following radical prostatectomy.Predicting Pathological Features at Radical Prostatectomy in Patients with Prostate Cancer Eligible for Active Surveillance by Multiparametric Magnetic Resonance Imaging.In-parallel comparative evaluation between multiparametric magnetic resonance imaging, prostate cancer antigen 3 and the prostate health index in predicting pathologically confirmed significant prostate cancer in men eligible for active surveillanceDoes index tumor predominant location influence prognostic factors in radical prostatectomies?Incorporating Oxygen-Enhanced MRI into Multi-Parametric Assessment of Human Prostate Cancer.Volumetry of the dominant intraprostatic tumour lesion: intersequence and interobserver differences on multiparametric MRI.The tumour hypoxia marker pimonidazole reflects a transcriptional programme associated with aggressive prostate cancer.Staging of prostatic carcinoma at 1.5-T MRI: correlation of a simplified MRI exam with whole-mount radical prostatectomy specimens.Size-adjusted Quantitative Gleason Score as a Predictor of Biochemical Recurrence after Radical Prostatectomy.Preoperative magnetic resonance imaging for detecting uni- and bilateral extraprostatic disease in patients with prostate cancer.18F-MK-9470 PET imaging of the type 1 cannabinoid receptor in prostate carcinoma: a pilot study.Performance of transrectal prostate biopsies in detecting tumours and implications for focal therapy.Ductal carcinoma of the prostate shows a different immunophenotype from high grade acinar cancer.Combined handling of prostate base/bladder neck and seminal vesicles in radical prostatectomy specimens: our approach with the whole mount technique.PTEN losses exhibit heterogeneity in multifocal prostatic adenocarcinoma and are associated with higher Gleason grade.Impact of body mass index on outcomes of laparoscopic radical prostatectomy with long-term follow-up.Impact of laparoscopic radical prostatectomy on clinical T3 prostate cancer: experience of a single centre with long-term follow-up.Evaluation of the major changes in eighth edition of the American Joint Committee on Cancer pathological staging for prostate cancer treated with prostatectomy.Eighth Edition of the UICC Classification of Malignant Tumours: an overview of the changes in the pathological TNM classification criteria-What has changed and why?UICC drops the ball in the 8th edition TNM staging of urological cancers.Prostate cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.Prostate cancer reporting and staging: needle biopsy and radical prostatectomy specimens.Total intraglandular and index tumor volumes predict biochemical recurrence in prostate cancer.Central pathology review of radical prostatectomy specimens does make a difference not only with grade.[TNM-Classification of localized prostate cancer : The clinical T-category does not correspond to the required demands].Re-evaluating the concept of “dominant/index tumor nodule” in multifocal prostate cancer
P2860
Q30563985-2DAD1912-CF85-4BD9-A8BE-80B2CD486B2FQ33566981-ADE499E0-B422-42E4-843E-3E219048789DQ33613656-DC6492F3-0E4E-499C-8CD7-9DAB39F6AFDEQ36575795-9F4C23C1-6D73-4923-8FB7-F039CE05C759Q37431041-888B761E-8451-4ED8-A983-60BE17595839Q37662669-B132A13E-21F7-48C7-A078-68BB7AC4743CQ38067446-F0A3775E-5F02-4159-8A51-DB9C50C931F3Q38109810-33C9DD24-6A98-4F11-B1E7-310D214FC57AQ38193586-3AFCE338-D29B-4AF2-806E-60AD4B2A4C68Q38211143-91D9026C-18F0-4E82-999B-164930FA25C6Q38384899-A81294BA-E9A6-4CF7-985B-E009F17F1065Q39350465-D5369E13-42B4-466A-80CF-52B63734B554Q39530354-7A9A1419-8D70-4D37-B191-7A06956DAE83Q39699690-E1A9EB1E-6523-4F5E-8433-0AFDD28F56BCQ39717982-8096407D-0984-4E1B-911B-15AE341A98EFQ40458086-144794B4-ADA1-456F-B4CC-EB2019658960Q40561072-3D5BDF35-7664-45D6-902A-592E292263B9Q41412161-8F42FE78-2703-4D42-B9D9-77A68890579BQ41664708-774FFD93-4D71-4A05-B858-2E4110B9C4B7Q41698475-F4752DD9-8FB2-42C4-BB66-0E253F87A733Q41740984-BD239B96-5D56-4975-B400-B9CDFE4F7A7FQ42083514-4C6655FA-EE74-41F1-BE27-E189DA5882FCQ42399332-B16E7EA6-A2C4-4085-B76B-1B0EAD5A2288Q42407054-63F6A575-C387-4AD7-8E11-DF895F236B8FQ42564268-C5BCD3EC-9BE4-4F6E-8A8A-19A6D8E8FAF0Q44544470-D1F0036D-AD81-4E0C-9A32-0C3BCAAF1CAAQ44747186-8ADA23EA-B672-44A8-9707-0EE2D7DA8FE9Q45036398-62384011-2C01-4134-A450-338C32509F55Q45359397-DA87C0EC-0BB1-4CF1-A723-84F7A31A8C2CQ45891100-4A169045-0704-4DA7-A217-A2A842997CEBQ46000322-A1ACCB3D-8556-46C8-91F5-E3C7856B2FF0Q47146186-E12A742A-A928-442A-9829-3E499DFBD520Q47361459-C6595D2C-FC89-462F-92D4-E61954662F9FQ48192470-0794B91C-A53C-431C-BDA7-929D0638C7D6Q48212490-72CBD607-C10E-4C50-92B7-DE1D54A1BD36Q48524997-6A7D4B82-3154-4080-98CE-ABAC4940D60BQ48674916-45411316-C4DA-4F8C-8F1C-DDC6A8219029Q50142583-99B05A29-F91A-43C0-97C7-E15B13DED3C9Q52845302-BFD729A7-2C84-4517-A747-93C5920843E7Q57385804-5E5D6C2A-45EE-44BD-9E3A-476A3F86ED2D
P2860
International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 2: T2 substaging and prostate cancer volume.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
International Society of Urolo ...... ng and prostate cancer volume.
@en
type
label
International Society of Urolo ...... ng and prostate cancer volume.
@en
prefLabel
International Society of Urolo ...... ng and prostate cancer volume.
@en
P2093
P2860
P1433
P1476
International Society of Urolo ...... ng and prostate cancer volume.
@en
P2093
Athanase Billis
Brett Delahunt
David Griffiths
ISUP Prostate Cancer Group
John R Srigley
Jonathan I Epstein
Mahul B Amin
Peter A Humphrey
Theo H van der Kwast
Thomas M Wheeler
P2860
P2888
P356
10.1038/MODPATHOL.2010.156
P577
2010-09-03T00:00:00Z